Pure Global

Lithium Quantitative Testing Drug - Vietnam Registration 230000152/PCBB-BYT

Access comprehensive regulatory information for Lithium Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 230000152/PCBB-BYT and manufactured by Siemens Healthcare Diagnostics Inc..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
230000152/PCBB-BYT
Registration Details
Vietnam MOH Registration: 230000152/PCBB-BYT
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Lithium Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng lithium
Risk Class TTBYT Loแบกi B

Registration Details

230000152/PCBB-BYT

000.00.04.G18-230223-0004

Atellica CH Lith_2

11532401

Company Information

Technical Details

The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis in the quantification of lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CH Analyzer. This test is used to support the monitoring of lithium therapy.

Dates and Status

Feb 23, 2023

Companies Making Similar Products
Companies providing products similar to "Lithium Quantitative Testing Drug"